絞り込み

16421

広告

A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?

著者 Dong SQ , Singh TP , Wei X , Yao H , Wang HL
Helicobacter.2017 Sep 08 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (136view , 0users)

Full Text Sources

Vonoprazan (VPZ) is a novel acid suppressant that has been used in Helicobacter pylori (H. pylori) eradication therapies in recent years. However, the efficacy and safety of VPZ vs proton-pump inhibitor (PPI) in H. pylori eradication therapies remain controversial.
PMID: 28884937 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード